&nbsp;

Aug 2025

Drug

trametinib

Other Name(s): Mekinist®

Quick Link(s):

Jun 2025

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Jun 2025

Regimen

TMZL

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

TRAM

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

Exceptional Access Program

trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria

Drugs Used:

trametinib

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

TOPO(W)

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

MFOLFOX6+PNTM

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

New Drug Funding Program

Panitumumab - In Combination with Chemotherapy for Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Panitumumab - First-Line Treatment for Left-Sided Metastatic Colorectal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

TMZL

Cancer Type:

Central Nervous System

Intent: Adjuvant

Funding:

ODB - General Benefit

temozolomide

Drugs Used:

temozolomide

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

MFOLFOX6

Cancer Type:

Gynecologic,

Ovary

Intent: Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

TMXFRIBO

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen,

ribociclib (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

MIDO

Cancer Type:

Hematologic,

Rare Diseases

Intent: Palliative

Drugs Used:

midostaurin (Unfunded)

Quick Link(s):

Regimen Monograph

Jun 2025

Drug

tucatinib

Other Name(s): Tukysa™

Quick Link(s):